Faculty

Institution

Unit

Venue

W. Ehmann

Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Medicine

Division of Hematology and Oncology

W. Ehmann is currently serving as a Medicine Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

W. Ehmann

Pennsylvania State University

Professor

You can click a keyword to filter the displayed items

medicine hematology oncology immunology pharmacology dermatology medicinal research immune responses cancer care clinical immunology lymphoid neoplasia cancer treatment cancer immunotherapy cancer research cellular therapy acute myeloid leukemia clinical trials hepatology pharmacotherapy cellular immune responses hematological malignancies tumor biology jama oncology medical mycology vascular biology cancer cells bone marrow transplantation cell transplantation inhibitory activity novel therapies cell therapy adaptive immune system cancer biology stem cell transplantation transplantation medicine maintenance rituximab enzyme inhibition leukemia molecular cancer brain tumor research stem cell research oncogenes early diagnosis therapeutic efficacy t-regulatory cell tolerance induction single-cell analysis immune checkpoint inhibitors treatment effects conformational studies remedial action bioassay-guided isolation immunohaematology immunopathology heme homeostasis thanatology biomedical modeling geriatric medicine later adulthood less rituximab rituximab extended schedule low-dose chemotherapy aids-related lymphoma zidovudine maintenance congenital afibrinogenemia anti-leukemia response aml patients high frequency induction rituximab overall response rate cephalosporin-induced hemolysis unfit patients first line treatment pathology stem cell mobilization haematopoiesis metabolomics

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab in Treating Patients Over 50 Years Old With Mantle Cell Lymphoma. Frontiers in Oncology (2024)

Jeffrey J. PuKristin N. BergerChunlei ZhengNhan DoDavid F. ClaxtonW. Christopher EhmannJoseph J. DrabickHaiquan LiThomas P. LoughranElliot M. Epner

medicinemantle cell lymphomalymphoid neoplasiaoncologycancer treatment

A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (Vcr) in Treating Elderly Patients With Mantle Cell Lymphoma. Research Square (2024)

Jeffrey J. PuKristin N. BergerChunlei ZhengNhan DoMary T. BrophyDavid F. ClaxtonW Christopher EhmannJoseph J. DrabickHaiquan LiThomas P. LoughranElliot M. Epner

elderly patientsdermatologymedicinepharmacologycancer caremantle cell lymphomahematologyoncologyclinical research

Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-Versus-Leukemia Model. The Journal of Immunology (2023)

Bei JiaChenchen ZhaoKentaro MinagawaHiroko ShikeDavid F. ClaxtonW. Christopher EhmannWitold B. RybkaShin MineishiMing WangTodd D. SchellK. Sandeep PrabhuRobert F. PaulsonYi ZhangLeonard D. ShultzHong Zheng

immunologymedicineclinical immunologyhematologyhumanized graft-versus-leukemia modelimmune responsesacute myeloid leukemia

The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (Vcr) in Treating Mantle Cell Lymphoma. Blood (2023)

Jeffrey J. PuKristin BergerChunlei ZhengNhan V DoDavid F. ClaxtonW Christopher EhmannJoseph J. DrabickThomas P. LoughranElliot Epner

medicinemantle cell lymphomacancer researchlymphoid neoplasiaoncologycancer treatment

Non-Myeloablative Allogeneic Stem Cell Transplant With Fludarabine and Reduced Dose Cyclophosphamide in Acute Myeloid Leukemia for Older Adults With Comorbidities. Bone Marrow Transplantation (2022)

Christopher J. PizzolaJoseph CioccioKevin L. RakszawskiMyles NickolichW. Christopher EhmannWitold B. RybkaBaldeep WirkSeema NaikHong ZhengBrooke SilarHiroko ShikeShouhao ZhouShin MineishiKentaro MinagawaDavid F. Claxton

later adulthoodbone marrow transplantationgeriatricsneurologymedicinecancer careolder adultshematologyacute myeloid leukemiastem cell transplantationdermatologyregenerative medicinegeriatric medicinetransplantation medicinecancer treatmentorgan transplantationoncologycell transplantationmedicinal researchclinical transplantation

Post-Transplant Cyclophosphamide Alters Immune Signatures and Leads to Impaired T Cell Reconstitution in Allogeneic Hematopoietic Stem Cell Transplant. Journal of Hematology & Oncology (2022)

Chenchen ZhaoMatthew BartockBei JiaNeal ShahDavid F. ClaxtonBaldeep WirkKevin L. RakszawskiMyles S. NickolichSeema G. NaikWitold B. RybkaW Christopher C. EhmannRaymond J. HohlJessica ValentinMichelle Bernas-PetersonEmily M. GerberMichele ZimmermanJoseph A. MierskiShin MineishiHong Zheng

immunologymedicinepharmacologyclinical immunologyhematologycellular immune responsescancer immunotherapyadaptive immune systemtransplantation medicineoncologyhepatologyimmune responsescell transplantationstem cell transplantation

A Novel Clinically Relevant Graft-Versus-Leukemia Model in Humanized Mice. Journal of Leukocyte Biology (2021)

Bei JiaChenchen ZhaoMichael BayerlHiroko ShikeDavid F ClaxtonW Christopher EhmannShin MineishiTodd D SchellPan ZhengYi ZhangLeonard D ShultzK Sandeep PrabhuRobert F PaulsonHong Zheng

immunologyhematological malignanciesdermatologybiomedical modelingcell therapyhematologyregenerative medicinecancer researchnovel therapieshumanized micecellular therapyoncologymedicinal researchcancer biologyclinical transplantation

A Phase I Clinical Trial of Avelumab in Combination With Decitabine as First Line Treatment of Unfit Patients With Acute Myeloid Leukemia. American Journal of Hematology (2020)

Hong ZhengShin MineishiDavid ClaxtonJunjia ZhuChenchen ZhaoBei JiaW. Christopher EhmannWitold B. RybkaSeema NaikNatthapol SongdejJoseph J. DrabickRaymond J. Hohl

medicinefirst line treatmentpharmacologyhematologypharmacotherapyclinical trialsunfit patientsacute myeloid leukemia

Multi‐Dimensional Analysis Identifies an Immune Signature Predicting Response to Decitabine Treatment in Elderly Patients With Aml. British Journal of Haematology (2019)

Chenchen ZhaoBei JiaMing WangTodd D. SchellDavid F. ClaxtonW Christopher EhmannWitold B. RybkaShin MineishiSeema NaikNatthapol SongdejJeff M. SivikRaymond J. HohlHui ZengHong Zheng

immunologyelderly patientsmedicineexperimental gerontologyclinical immunologyhematologyimmunohaematologythanatologyheme homeostasisimmune signaturehepatologyclinical epidemiologymedicinal researchimmunopathologytranslational medicinehealth sciencespharmacological researchimmunotherapy

Bone Marrow Cd8 T Cells Express High Frequency of Pd-1 and Exhibit Reduced Anti-Leukemia Response in Newly Diagnosed Aml Patients. Blood Cancer Journal (2018)

Bei JiaLiru WangDavid F. ClaxtonW Christopher EhmannWitold B. RybkaShin MineishiSyed RizviHiroko ShikeMichael BayerlTodd D. SchellRaymond J. HohlHong Zheng

hematological malignanciescellular immune responsesbone marrow transplantationaml patientshigh frequencymedicinehematologyimmune responsescancer biologydermatologyleukemiacancer researchsingle-cell analysiscancer immunotherapyimmunologyclinical immunologycellular therapyoncologymedicinal researchcancer cellsanti-leukemia response

1
2
10 / page

W. Ehmann

Professor

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Medicine

Division of Hematology and Oncology

W. Ehmann is currently serving as a Medicine Professor at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

W. Ehmann

Pennsylvania State University

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab in Treating Patients Over 50 Years Old With Mantle Cell Lymphoma. Frontiers in Oncology (2024)

Jeffrey J. PuKristin N. BergerChunlei ZhengNhan DoDavid F. ClaxtonW. Christopher EhmannJoseph J. DrabickHaiquan LiThomas P. LoughranElliot M. Epner

medicinemantle cell lymphomalymphoid neoplasiaoncologycancer treatment

A Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (Vcr) in Treating Elderly Patients With Mantle Cell Lymphoma. Research Square (2024)

Jeffrey J. PuKristin N. BergerChunlei ZhengNhan DoMary T. BrophyDavid F. ClaxtonW Christopher EhmannJoseph J. DrabickHaiquan LiThomas P. LoughranElliot M. Epner

elderly patientsdermatologymedicinepharmacologycancer caremantle cell lymphomahematologyoncologyclinical research

Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-Versus-Leukemia Model. The Journal of Immunology (2023)

immunologymedicineclinical immunologyhematologyhumanized graft-versus-leukemia modelimmune responsesacute myeloid leukemia

The Final Results of a Phase I Study Using Bortezomib (Velcade), Cladribine, and Rituximab (Vcr) in Treating Mantle Cell Lymphoma. Blood (2023)

Jeffrey J. PuKristin BergerChunlei ZhengNhan V DoDavid F. ClaxtonW Christopher EhmannJoseph J. DrabickThomas P. LoughranElliot Epner

medicinemantle cell lymphomacancer researchlymphoid neoplasiaoncologycancer treatment

Post-Transplant Cyclophosphamide Alters Immune Signatures and Leads to Impaired T Cell Reconstitution in Allogeneic Hematopoietic Stem Cell Transplant. Journal of Hematology & Oncology (2022)

A Novel Clinically Relevant Graft-Versus-Leukemia Model in Humanized Mice. Journal of Leukocyte Biology (2021)

Bei JiaChenchen ZhaoMichael BayerlHiroko ShikeDavid F ClaxtonW Christopher EhmannShin MineishiTodd D SchellPan ZhengYi ZhangLeonard D ShultzK Sandeep PrabhuRobert F PaulsonHong Zheng

A Phase I Clinical Trial of Avelumab in Combination With Decitabine as First Line Treatment of Unfit Patients With Acute Myeloid Leukemia. American Journal of Hematology (2020)

Hong ZhengShin MineishiDavid ClaxtonJunjia ZhuChenchen ZhaoBei JiaW. Christopher EhmannWitold B. RybkaSeema NaikNatthapol SongdejJoseph J. DrabickRaymond J. Hohl

medicinefirst line treatmentpharmacologyhematologypharmacotherapyclinical trialsunfit patientsacute myeloid leukemia

Multi‐Dimensional Analysis Identifies an Immune Signature Predicting Response to Decitabine Treatment in Elderly Patients With Aml. British Journal of Haematology (2019)

Chenchen ZhaoBei JiaMing WangTodd D. SchellDavid F. ClaxtonW Christopher EhmannWitold B. RybkaShin MineishiSeema NaikNatthapol SongdejJeff M. SivikRaymond J. HohlHui ZengHong Zheng

Bone Marrow Cd8 T Cells Express High Frequency of Pd-1 and Exhibit Reduced Anti-Leukemia Response in Newly Diagnosed Aml Patients. Blood Cancer Journal (2018)

Bei JiaLiru WangDavid F. ClaxtonW Christopher EhmannWitold B. RybkaShin MineishiSyed RizviHiroko ShikeMichael BayerlTodd D. SchellRaymond J. HohlHong Zheng

1
2
10 / page

Similar Faculty Members

Brenda W. Cooper

Institution

Case Western Reserve University

medicine

hematology

Marco Ruella

Institution

University of Pennsylvania

cell therapy

immunomodulation

Sunita D Nasta

Institution

University of Pennsylvania

oncology

medicine

Saar I. Gill

Institution

University of Pennsylvania

immunology

medicine

David Claxton

Institution

Pennsylvania State University

metabolomics

hematological malignancies

Peter Greenberg

Institution

Stanford University

hematology

medicine

Robert Baiocchi

Institution

Ohio State University

evolutionary data mining

optimization-based data mining

Francesco Maura

Institution

University of Miami

hematology

immunology

Jennifer Woyach

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Selina M. Luger

Institution

University of Pennsylvania

hematology

medicine

Similar Faculty Members

Brenda W. Cooper

Institution

Case Western Reserve University

medicine

hematology

Marco Ruella

Institution

University of Pennsylvania

cell therapy

immunomodulation

Sunita D Nasta

Institution

University of Pennsylvania

oncology

medicine

Saar I. Gill

Institution

University of Pennsylvania

immunology

medicine

David Claxton

Institution

Pennsylvania State University

metabolomics

hematological malignancies

Peter Greenberg

Institution

Stanford University

hematology

medicine

Robert Baiocchi

Institution

Ohio State University

evolutionary data mining

optimization-based data mining

Francesco Maura

Institution

University of Miami

hematology

immunology

Jennifer Woyach

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Selina M. Luger

Institution

University of Pennsylvania

hematology

medicine